muscular dystrophies

25 проекта

HEИндивидуална стипендия2026–2028Франция

SKM-REFORMAT · SKeletal Muscle - REgulation of FORce and Maturation through Tubulin isotypes

HEДокторантска мрежа2025–2029Франция

ENTRY-DM · Interdisciplinary doctoral training on oligonucleotide-based therapies for myotonic dystrophy

29 партньори · 9 държави

HEИндивидуална стипендия2024–2027Италия

MyoPALM · Deciphering the role of protein S-palmitoylation in skeletal muscle physiopathology

2 партньори · 2 държави

H2020Индивидуална стипендия2021–2024Италия

Myo_LysoZOOM · An insight into lysosomal signature in muscle wasting

2 партньори · 2 държави

H2020Индивидуална стипендия2021–2023Франция

MUMDUPSC · Modelling undiagnosed muscular dystrophies using patients's stem cells

H2020Индивидуална стипендия2021–2025Франция

DYSTROPHIC-ECM · Active role of skeletal muscle extracellular matrix in muscular dystrophies

H2020Индивидуална стипендия2021–2023Италия

DREAM · Dux4-Regulated Expression and Activity by an inhibitor Molecule

H2020Индивидуална стипендия2020–2022Обединеното кралство

RE-GENESis · GENome Editing and delivery Strategies for REcoding the mammalian genome

H2020Индивидуална стипендия2019–2022Гърция

MechanoGenetic · Role of mechanical forces in cell-matrix adhesion sites

H2020Индивидуална стипендия2018–2020Нидерландия

DUX4 · Function of DUX4 in skeletal muscle and non-muscle tissues

H2020Индивидуална стипендия2017–2019Швейцария

MuSCel Genome · Muscle Specific C. elegans Genome in health and disease: finding novel factors in 3D organization

H2020Индивидуална стипендия2017–2019Германия

VGAP · The Viral Genome Associated Proteome

H2020Индивидуална стипендия2017–2019Франция

DMD2CURE · Correction of duplications in the DMD gene by a CRISPR/Cas9 approach

H2020Индивидуална стипендия2016–2018Израел

channelopathies · Type 1 reyanodine receptor Structure and regulation by post-translational modifications and small molecules.

H2020Индивидуална стипендия2016–2017Обединеното кралство

Subpopulations · Investigating Fibrotic and Regenerative Fibroblast Populations in Muscular Dystrophy

H2020Индивидуална стипендия2016–2017Обединеното кралство

DYS_FUNCTION · Novel use of exon skipping technology to study structure-function relationship of dystrophin

H2020Индивидуална стипендия2016–2018Обединеното кралство

INAME · Imaging nucleic acid metabolism in cells

H2020Индивидуална стипендия2015–2017Дания

PIOMES · Pbx proteins as pioneer factors promoting signal specificity in mesodermal differentiation

FP7Реинтеграция2013–2017Испания

ANTES · Accelerating Neuromuscular Treatment Selection

FP7Реинтеграция2010–2014Испания

LGMD2A · Development of a strategy to treat limb-girdle muscular dystrophy (LGMD2A) using combined cell and gene therapy strategies

2 партньори

FP7Индивидуална стипендия2010–2012Испания

STROKECELLFUSION · Cell fusion as regenerative tool for stroke treatment

FP6Реинтеграция2006–2008Италия

FSHD ANIMAL MODEL. · An animal model to develop therapeutic strategies for facioscapulohumeral muscular dystrophy, FSHD

FP6Индивидуална стипендия2005–2007Франция

DM BRAIN · Dissecting the molecular pathways of brain dysfunction in myotonic dystrophy

FP5Индивидуална стипендия2002–2003Италия

Real-time analysis of the induction of apoptosis in duchene muscular dystrophy